ライフサイエンスコーパス: microarray

1 and presence of autoantibody was detected by microarray.

2 llergens and two irritants were analyzed via microarray.

3 oarray, we used the BUGS Bioscience Senti-SP microarray.

4 recipients post-transplantation by allergen microarray.

5 g site was performed via overlapping peptide microarray.

6 ffected and control horses using an allergen microarray.

7 efficient mass transfer of an analyte onto a microarray.

8 geal pneumococci were molecular-serotyped by microarray.

9 nalysis, and mRNA expression was analyzed by microarray.

10 Gene expression profiles were analyzed via microarray.

11 o epoxy glass slides as an O-glycome shotgun microarray.

12 try panel, and 540,000 transcript expression microarray.

13 al cells of 309 SAM children using the 450 K microarray.

14 immunohistochemical analysis of PDAC tissue microarray.

15 by IgE of PA compared to PS patients on the microarray.

16 s in gene expression using a gene expression microarray.

17 d control individuals were analyzed by miRNA microarray.

18 ily obtained from whole-genome sequencing or microarrays.

19 chain reaction, functional analysis, and RNA microarrays.

20 RNA was isolated and assayed on whole genome microarrays.

21 ell lines and human pancreatic cancer tissue microarrays.

22 ted KS tissue samples and KS visceral tissue microarrays.

23 erase chain reaction (real-time RT-PCR), and microarrays.

24 levels of PRL and PRLR in multitumor tissue microarrays.

25 n challenging using glass slide-based glycan microarrays.

26 pectives on the design of functional smectic microarrays.

27 Score (RS), Prosigna Prediction Analysis of Microarray 50 (PAM50) Risk of Recurrence (ROR), EndoPred

28 We used yeast proteome microarrays (~5800 purified proteins) to conduct a high-

29 glycans bound by CHIKV, we conducted glycan microarray analyses and discovered that CHIKV preferenti

30 We performed microarray analyses of peripheral blood mononuclear cell

31 p/19q testing was performed with chromosomal microarray analysis (CMA).

32 gingival transcriptome was determined with a microarray analysis and focused on the expression level

33 We used microarray analysis and immunohistochemistry (IHC) to ex

34 gene expression profiles were determined by microarray analysis and quantitative RT-PCR, and express

35 Microarray analysis and single-cell RNA sequencing revea

36 f the myelination process, here we adopted a microarray analysis approach combined with laser-capture

37 Tissue microarray analysis identified a correlation between abs

38 Microarray analysis identified dynamic changes in the tr

39 In Fto-deficient arteries, microarray analysis identified upregulation of L-Pgds wi

40 Microarray analysis of GEN-exposed uteri during early pr

41 Via next-generation microarray analysis of leukocyte RNA we found that long

42 tive, non-neutralizing mAb was determined by microarray analysis of peptides generated from the VP1 c

43 On-chip microarray analysis of serum biomarkers (e.g., cardiac t

44 Microarray analysis of SFRP1 in periampullary adenocarci

45 (RNA-induced Silencing Complex) followed by microarray analysis of the RISC-bound miRNA targets (RIP

46 Microarray analysis of ventricular tissue revealed that

47 A microarray analysis performed on FRDA patient's lymphobl

48 Microarray analysis revealed age-related changes in mult

49 Tissue microarray analysis revealed co-expression correlations

50 Microarray analysis revealed downregulation of matrisome

51 A gene expression assessment by microarray analysis revealed FA affected FSK cells by al

52 Microarray analysis revealed upregulated mesenchymal gen

53 Microarray analysis showed that romidepsin altered early

54 ng underlying BBB maturation, we performed a microarray analysis that identified Fgfbp1 as a novel Wn

55 Microarray analysis was conducted to identify iAs-dysreg

56 Microarray analysis was then used to profile the differe

57 Instead, using microarray analysis we have elucidated that ERalpha-medi

58 regulated genes detected via custom-designed microarray analysis were validated using qPCR.

59 center cohort study, we integrated allograft microarray analysis with extensive clinical and histolog

60 pression pattern was profiled by genome-wide microarray analysis, and direct gene targets were identi

61 T cells, comparing them to Tc1 clones using microarray analysis.

62 performed knockdown of EPB41L4A followed by microarray analysis.

63 ding the identified SHs were monitored using microarray analysis.

64 volved in cell migration/motility based on a microarray analysis.

65 mphopenia underwent testing with chromosomal microarray analysis.

66 ge as determined by immunohistochemistry and microarray analysis.

67 filing of algae single cells with a 120-well microarray and identified more than 50 lipids in C. rein

68 rioamniotic membranes were studied using RNA microarray and immunohistochemistry.

69 Cytokine profiles were evaluated by proteome microarray and Kaplan-Meier survival analysis was used t

70 Large-scale microarray and mass spectrometric analyses revealed sign

71 Use of chromosomal microarray and massively parallel sequencing technologie

72 ive biomarker genes in different tumors, and microarray and metabolomics data from Arabidopsis thalia

73 en widely used for DNA immobilization in DNA microarray and numerous bioassays for decades, whereas t

74 nd 96.6% (95% CI, 95.5 to 97.5%) between the microarray and PneumoCaT.

75 By using Tn-Seq, RNA-Seq, microarray and proteomics datasets from two human pathog

76 Protein microarray and pulldown experiments revealed that this i

77 Microarray and qPCR analysis of gastrocnemius muscle RNA

78 ive and osmotic stresses were assessed using microarray and reverse transcriptase quantitative PCR.

79 nd healthy control groups were identified by microarray and reverse transcription-quantitative PCR (q

80 Microarray and RNA sequence of S1pr2(-/-) mouse epidermi

81 lyzing 8 transcriptional profiling datasets (microarray and RNA sequencing) spanning 43 generations o

82 When analyzed by microarray and RNA sequencing, the resistant NSCLC cell

83 re available for sample size calculation for microarray and RNA-seq in the context of differential ex

84 tic comparison with various state-of-the-art microarray and RNA-seq networks was also performed, howe

85 Over recent years, large amount of microarray and RNA-Sequencing datasets have been collect

86 ants, and gene expression was measured using microarray and RT quantitative PCR.

87 Integration of microarray and sequencing data enabled the description o

88 Microarray and SPR assays of structurally defined HS oli

89 antibodies, as defined by binding to glycan microarrays and by affinity purification.

90 in situ hybridization of two prostate tissue microarrays and by laser-capture microdissection of pros

91 Genome-wide microarrays and cytokine profiling were used to interrog

92 Assessment of Y chromosome in NSCLC tissue microarrays and expression of linc-SPRY3-2/3/4 in NSCLC

93 ed the analysis of gene expression profiling microarrays and gene methylation profiling microarrays,

94 plexes on solid substrates is widely used in microarrays and lateral flow tests.

95 n the tetrodotoxin model, we used 16-channel microarrays and microwires to record electrophysiologica

96 With cross-subtype peptide microarrays and multiplex binding assays, we probed the

97 tforms: CombiMatrix and NimbleGen expression microarrays and RNA sequencing.

98 shed and emerging research disciplines, from microarrays and smart surfaces to tissue engineering.

99 Using peptide microarrays and tandem MS-based analysis methods, we sho

100 o 96.3%) between latex agglutination and the microarray, and 96.6% (95% CI, 95.5 to 97.5%) between th

101 e studied using immunohistochemistry, tissue microarray, and digital image analysis in 141 BC patient

102 equencing (WES), RNA sequencing, methylation microarray, and immunohistochemistry (IHC) on 8 pairs of

103 ccordant (PCC >0.95) with those derived from microarray, and they were substantially less variable if

104 for cell-surface engineering, development of microarrays, and drug delivery systems.

105 analyses, immunohistochemistry-based tissue microarrays, and various cell biology assays, we demonst

106 Glycan microarrays are capable of illuminating the interactions

107 In this work, a user-friendly DNA microarray assay was developed for the authentication of

108 cRNAs, miRNA, and mRNA were identified using microarray-based analysis and verified in tumor r cell l

109 commonly associated with the development of microarray-based assays are nonspecific binding and diff

110 2017 and August 2019 was conducted using DNA microarray-based assays.

111 Microarray-based examination of peptides revealed charge

112 We used microarray-based profiling to discover deregulated miRNA

113 We combine a microarray-based spatial transcriptomics method that rev

114 Three studies used microarray-based technologies to examine DNA methylation

115 mined the transcripts by Affymetrix GeneChip microarray before gastrulation.

116 ormance on gene expression data generated by microarray, bulk RNA-Seq and scRNA-Seq.

117 A low-cost microfluidic microarray capable of lysing cells and quantifying prote

118 base, and analysis of human RCC tumor tissue microarrays, cDNA arrays and tumor biopsy samples demons

119 Liquid chromatography-mass spectrometry and microarray characterization of 5ASKH strains revealed su

120 n molecules was measured by using the MedALL microarray chip (n = 1021).

121 Microarray classifier analysis has shown promise in the

122 Our findings suggest that using a microarray classifier analysis, not only can we create d

123 We analyzed a miR microarray comparing with normal and PNF SCs and identif

124 ntally verified GRNs and corresponding large microarray compendium data.

125 In a tissue microarray comprised of 363 primary human breast tumors,

126 We generated an allergome-wide microarray comprising 731 allergens in the form of more

127 Human fibrosis microarrays conducted using LX-2 cell RNA derived from M

128 e analyzed longitudinally using a Pf protein microarray covering 91% of the proteome, providing first

129 control groups, using the linear models for microarray data (linear modeling) and Boruta (decision t

130 co-expression analysis of publicly available microarray data (n = 303 profiles) measured in livers of

131 To facilitate analysis of glycan microarray data alongside protein structure, we have bui

132 RNA-seq and microarray data analyses of the putative GLCAT genes rev

133 However, it is difficult to interpret microarray data and identify structural determinants pro

134 ords, and subtypes were determined by tissue microarray data and pathology reports.

135 Cutaneous lupus erythematosus lesional skin microarray data and RNA sequencing data from SLE keratin

136 Available microarray data enabled direct comparison of polygenic r

137 base query, and allows users to upload their microarray data for analysis.

138 mans, we screened whole exome sequencing and microarray data from a clinical cohort.

139 along with high-resolution postmortem brain microarray data from Allen Brain Atlas (donors n = 6) fr

140 Although microarray data from diseased patient kidneys and fibrot

141 We used microarray data from UK Biobank to investigate the preva

142 Microarray data gained with these DCs showed a significa

143 ost gene expression signatures obtained from microarray data of B. pseudomallei-infected cases to dev

144 mRNA transcriptome data from newly generated microarray data on IHs with publicly available data on t

145 ion of linc-SPRY3-2/3/4 in NSCLC RNA-seq and microarray data revealed a negative correlation between

146 GA stress using existing RNA sequencing and microarray data sets generated using human islets from d

147 By analyzing two publicly available microarray data sets, we found that NPFF is consistently

148 naling molecular targets by meta-analysis of microarray data sets.

149 ome analysis coupled with publicly available microarray data suggested a mechanism of impaired PLGA d

150 The unique feature of GlyMDB is to link microarray data to PDB structures.

151 We preprocessed the microarray data using the Robust Multichip Average (RMA)

152 RNAseq and microarray data were obtained for 1032 gliomas from the

153 sed search is performed using BLAST to match microarray data with all available PDB structures contai

154 In a subpopulation with microarray data, IgE to the major timothy grass allergen

155 PARZ trial, 375 (83%) patients had available microarray data, pretreatment BMI measurements, and over

156 comparative analysis between proteomics and microarray data, significantly higher degrees of correla

157 Using data mining techniques on existing microarray data, we found that mRNA expression of the CS

158 using Biobank of Karolinska Endarterectomies microarray data.

159 expression over time, using bulk RNA-seq or microarray data.

160 essfully validated the original EBV proteome microarray data.

161 ions were mainly made in trials and based on microarray data.

162 protein structure, we have built the Glycan Microarray Database (GlyMDB), a web-based resource inclu

163 The classifier utilizes a large composite microarray dataset (15 individual datasets), an individu

164 sifier was validated using a gene expression microarray dataset.

165 genesis of endometriosis, we recruited 3 raw microarray datasets (GSE11691, GSE7305, and GSE12768) fr

166 PGSs were recapitulated in four independent microarray datasets from Gene Expression Omnibus and wer

167 Using accumulated microarray datasets from the grapevine whole-genome arra

168 ature and identified a number of RNA-Seq and microarray datasets in order to develop, train, test, an

169 We demonstrate on the three microarray datasets that our method is capable of identi

170 miRNA microarray demonstrated that the expression of miR-216a

171 2 protein expression as determined by tissue microarray derived from NKTL patients.

172 braries by compartmentalizing and assembling microarray-derived oligonucleotides in vortexed emulsion

173 The microarray detected anti-GM1a antibodies with high sensi

174 DNA microarrays (DNA chips) with species-specific oligonucle

175 Polymer microarrays enable the high-throughput comparison of mat

176 ndexing (CODEX) for paraffin-embedded tissue microarrays, enabling simultaneous profiling of 140 tiss

177 This method was tested on microarray expression data from the M3D database, corres

178 can-binding proteins due to the ambiguity in microarray fluorescence intensity and complexity in bran

179 ctively processed using a commercial protein microarray fluorescent test.

180 ome sequencing (WGS) with PneumoCaT, and DNA microarray for samples from community carriage surveilla

181 ogy to a ToF-SIMS image of a printed polymer microarray for the first time.

182 Next, the potential of CPS microarrays for detecting recognition by anti-CPS IgGs w

183 d by immunohistochemistry analyses of tissue microarrays for loss of MLH1, MSH2, MSH6, and/or PMS2.

184 So far, though, only DNA microarrays for the authentication of land vertebrate sp

185 of 12 allergen extracts or pure proteins in microarray format, as a proof of concept.

186 Microarray found that compared with their levels of expr

187 Lung tumor tissue microarrays from 104 patient samples were constructed.

188 d large-scale immunohistochemistry in tissue microarrays from 1552 patients reveal that ZAP is preval

189 ely analyzed expression of ANGPTL2 in tissue microarrays from I-BLCA and surprisingly found an opposi

190 days 0, 4, 14, 42, and 84 and processed for microarray gene expression analysis.

191 veral publicly available protein expression, microarray gene expression and single-cell transcriptome

192 RNA was analysed by microarray gene profiling using the Illumina HumanHT-12

193 here are >2 million publicly-available human microarray gene-expression profiles, these profiles were

194 uently, the PCR results were integrated with microarray genotypes (Illumina Human Omni 1S-8), obtaine

195 ion interferometry and image processing of a microarray glass biochip, affordable to be single-used i

196 d fidelity, using side-by-side comparison of microarray grids, triangles incorporating angles 15-90 d

197 We downloaded data of gene expression microarrays (GSE20347, GSE38129) and gene methylation mi

198 ys (GSE20347, GSE38129) and gene methylation microarrays (GSE52826) from the Gene Expression Omnibus

199 Protein microarrays have been successfully used for detection of

200 were tested for IgE and IgG reactivity to 15 microarrayed HDM allergen molecules with ImmunoCAP Immun

201 nd robustness by a systematic benchmark with microarray, high-coverage whole-exome and -genome approa

202 nd European populations, we used genome-wide microarray, HLA high-resolution typing and AQP4 gene seq

203 Protein microarray identified 366 non-HLA antibodies (>1.5 fold,

204 Analyses of AKT-related genes using microarray, immunoblotting, and real-time quantitative P

205 tions with karyotype testing and chromosomal microarray in an unselected cohort of sequential pregnan

206 We measured gene expression by microarrays in 235 liver transplant biopsies from 10 cen

207 Spectra have been obtained from protein microarrays in a high throughput process.

208 using RNAseq in EvA (n = 283) and Affymetrix microarrays in U-BIOPRED (n = 85).

209 at low relative abundances (median, 8%), the microarray increased VT detection by 31.5% over that by

210 ology in two cohorts using custom genotyping microarrays, large imputation reference panels, and func

211 ides, and cell activation determined using a microarray laser scanner.

212 Peptide microarrays may help to identify immunogenic epitopes, d

213 of gene regulatory networks (GRNs) from DNA microarray measurements forms a core element of systems

214 Polysome analyses were combined with microarray measurements to identify gene transcripts who

215 This method that combines microarrays, MEF, and MALDI-MS presents an effective pla

216 ling was performed with 3D-Gene global miRNA microarray mouse chips encompassing all mouse miRNAs ava

217 ed, however, none outperformed the aggregate microarray network despite having good predictive perfor

218 We performed a comparative microarray of the embryonic distal hindgut of wild-type

219 Microarray of thyroid RNA displayed incomplete overlap b

220 Microarrays of carotid arteries from Pcsk6(-/-) versus c

221 Tissue microarrays of human lung cancers indicated the expressi

222 serum, the newly developed S. pneumoniae CPS microarrays offer the advantage of enabling the simultan

223 We report a multiplex label-free antigen microarray on the Arrayed Imaging Reflectometry (AIR) pl

224 ies of urothelial carcinomas (UCs) by tissue microarray, on which histologic variants and molecular s

225 quantitative measurement techniques, such as microarray or fluorescence polarization assays.

226 s on major depressive disorder that reported microarray or RNA sequencing measurements on whole blood

227 rthermore, the platform used to measure MIF (microarray or RNAseq) was found to influence the splice

228 allele dosage information, such as that from microarray or sequencing experiments.

229 xpression 47 (BASE47) predictive analysis of microarrays (PAM) classifier.

230 The Vaxxas high-density microarray patch (HD-MAP) consists of a high density of

231 Microarray patches (MAPs) offer the possibility of impro

232 A miR microarray performed in primary human conjunctival epith

233 The first microarrays performed with betalains and biological conf

234 This universal microarray platform provides an unprecedented opportunit

235 The microarray platform provides enzyme kinetics of hundreds

236 The Affymetrix HGU133plus2 microarray platform was employed to identify gene expres

237 ples with data perturbation due to different microarray platforms.

238 ycoside dye quantification and comprehensive microarray polymer profiling of sequentially extracted c

239 ific IgGs in serum, using a collection of 22 microarray-printed S. pneumoniae CPSs.

240 nt sensor-encoding lentiviral vectors with a microarray printer enables parallel recording of multipl

241 sis by MS, as well as functional analysis by microarray printing and screening using a prototypical H

242 y IL-17 in keratinocytes were evaluated with microarray profiling and reverse transcriptase-PCR.

243 microdissection coupled with custom-designed microarray profiling to determine the genetic signature

244 By gene microarray profiling with bioinformatics analysis, we fo

245 spanning from immunohistochemistry (IHC), to microarrays (protein, DNA), to high-throughput screens r

246 lciparum malaria were analyzed using protein microarrays (Protoplex Immune Response Assay, ThermoFish

247 uation on multiple datasets-first-generation MicroArray Quality Control (MAQC) brain and Universal Hu

248 n an independent validation dataset from the Microarray Quality Control (MAQC)-II study.

249 cell lines were analyzed by gene-expression microarray, quantitative polymerase chain reaction, immu

250 vaccination, we designed protein and peptide microarrays representing hundreds of unique AMA1 variant

251 Microarray results also indicate that sulfate groups on

252 Microarrays revealed that the transmembrane glycoprotein

253 er coronavirus infection-related genes using microarray, RNA sequencing, and 10x single-cell transcri

254 multiple imputation tasks (within and across microarray/RNA-seq datasets) establishes that SampleLASS

255 ce including a searchable database of glycan microarray samples and a toolset for data/structure anal

256 complete transcriptome in partially-measured microarray samples by imputing the expression of unmeasu

257 ycan-binding motif discovery for 5203 glycan microarray samples collected from the Consortium for Fun

258 uorescence intensity data from two different microarray samples.

259 d by Immunohistochemistry (IHC) using tissue microarray sections containing both normal and cancerous

260 The Cancer Genome Atlas database and tissue microarrays showed strong correlation between the major

261 Analysis of human gastric cancer tissue microarrays, showed high levels of DARPP-32 and positive

262 g microarrays and gene methylation profiling microarrays, simultaneously, and in this way, it can she

263 nut allergens (Ara h 1-11) were spotted onto microarray slides, and patients' samples were tested for

264 large family-based cohorts, of high-density microarray studies of submicroscopic chromosomal structu

265 d datasets of transcript analyses made using microarray studies of WF-exposed tissues and of cancers,

266 a gene list from peer-reviewed comprehensive microarray studies that discovered and validated their u

267 profiles in human ROSMAP datasets and mouse microarray studies.

268 e from young, old and OA knees was used in a microarray study to identify alterations in snoRNA expre

269 aset (15 individual datasets), an individual microarray study, and an RNA-Seq dataset, using gene rat

270 e perfluoroalkyl chains are removed from the microarray surface along with nonspecifically adsorbed p

271 sence of the method consists in blocking the microarray surface with a blocking agent containing a pe

272 or Lyme disease are measured using a protein microarray system, Lyme Immunochip, in a single step but

273 emiautomatically process data from different microarray technologies, we were able to determine the m

274 s work, we examined the applicability of the microarray technology to detect CPS type-specific IgGs i

275 ghput genomic technologies is the genotyping microarray technology, which can genotype millions of si

276 severity using a ferret model and our lectin microarray technology.

277 eriodic textures that can be used as optical microarrays, templates for soft lithography, and orderin

278 ched DNA was hybridized to a custom promoter microarray (termed ChIP-chip).

279 a subset of the samples assayed on Illumina microarrays that achieved a ROC-AUC of 0.847 on independ

280 Using microarrays that contained > 1,000 glycans, including an

281 s and immunohistochemical analyses of tissue microarrays that contained BE tissues from 100 patients

282 ma specimens analyzed by IHC on tumor tissue microarray (TMA) cores and by gene expression profiling

283 Tissue microarray (TMA) samples from 415 tissues collected from

284 Tissue Microarrays (TMA) were constructed from these samples.

285 es, patient-derived xenografts (PDX), tissue microarrays (TMA), and The Cancer Genome Atlas (TCGA) da

286 prostatectomy specimens (embedded in tissue microarrays [TMAs]) from 483 patients treated in 3 Canad

287 g ganglio-oligosaccharides were printed as a microarray to examine binding specificities of lectins,

288 S oligosaccharides, were printed as a glycan microarray to examine the binding selectivities of sever

289 data from UALCAN and human pancreatic tissue microarrays to compare levels of PRKD1 between tumor and

290 Using bulk RNA sequencing or microarray transcriptomics from tissue samples (4 SB and

291 Methods: A tissue microarray was built from 36 HCC samples and from matchi

292 A peptide microarray was designed to screen for immunoglobulin G t

293 est, a glycan and an allergen (glyco)protein microarray, we mapped IgE fine specificity among Ugandan

294 For molecular serotyping by microarray, we used the BUGS Bioscience Senti-SP microar

295 r, WGS, which adds population structure, and microarray, which adds multiple-serotype carriage, shoul

296 ), polymerase chain reaction (PCR), and gene microarrays, which are labor-intensive and time-consumin

297 ed classification of Pfn1 staining in tissue microarrays, which indicated Pfn1 positivity in both tum

298 This microarray will be a powerful tool for the development o

299 ing the high-throughput potential of protein microarrays with the biologically relevant readout provi

300 nufacturing high-density multiplexed protein microarrays with the capacity to detect low levels of an